$676 Million is the total value of Novo Holdings A/S's 22 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 21.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INGN | INOGEN INC | $338,499,000 | -23.2% | 3,549,320 | 0.0% | 50.08% | -19.3% | |
| GKOS | GLAUKOS CORP | $47,435,000 | +39.5% | 605,266 | 0.0% | 7.02% | +46.6% | |
| CABO | New | CABLE ONE INC | $44,162,000 | – | 45,000 | +100.0% | 6.53% | – |
| KIDS | ORTHOPEDIATRICS CORP | $28,951,000 | +26.8% | 654,549 | 0.0% | 4.28% | +33.3% | |
| FOLD | AMICUS THERAPEUTICS INC | $25,403,000 | +42.0% | 1,867,870 | 0.0% | 3.76% | +49.2% | |
| AKBA | AKEBIA THERAPEUTICS INC | $25,389,000 | +48.1% | 3,100,000 | 0.0% | 3.76% | +55.7% | |
| AERI | AERIE PHARMACEUTICALS INC | $21,409,000 | +31.6% | 450,714 | 0.0% | 3.17% | +38.2% | |
| SPNE | SEASPINE HLDGS CORP | $19,725,000 | -17.3% | 1,308,037 | 0.0% | 2.92% | -13.1% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $17,770,000 | +9.5% | 4,420,516 | 0.0% | 2.63% | +15.1% | |
| SIBN | Buy | SI BONE INC | $16,818,000 | -9.8% | 892,685 | +0.0% | 2.49% | -5.2% |
| ETTX | ENTASIS THERAPEUTICS HLDGS I | $14,749,000 | +66.1% | 2,181,843 | 0.0% | 2.18% | +74.6% | |
| GLPG | Buy | GALAPAGOS NVspon adr | $11,481,000 | +43.0% | 97,481 | +11.4% | 1.70% | +50.3% |
| NABRIVA THERAPEUTICS PLC | $11,477,000 | +67.1% | 4,703,720 | 0.0% | 1.70% | +75.6% | ||
| INSP | INSPIRE MED SYS INC | $9,937,000 | +34.4% | 175,000 | 0.0% | 1.47% | +41.2% | |
| XLRN | Sell | ACCELERON PHARMA INC | $9,233,000 | -49.6% | 198,261 | -52.8% | 1.37% | -47.0% |
| STIM | NEURONETICS INC | $8,006,000 | -21.2% | 525,000 | 0.0% | 1.18% | -17.2% | |
| MRUS | MERUS N V | $7,426,000 | +5.5% | 502,795 | 0.0% | 1.10% | +10.9% | |
| BPMC | New | BLUEPRINT MEDICINES CORP | $5,409,000 | – | 67,567 | +100.0% | 0.80% | – |
| VRNA | VERONA PHARMA PLCsponsored ads | $4,815,000 | -32.6% | 740,740 | 0.0% | 0.71% | -29.2% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $3,073,000 | -24.1% | 135,009 | 0.0% | 0.46% | -20.2% | |
| DERM | Sell | DERMIRA INC | $2,724,000 | -81.0% | 201,059 | -89.9% | 0.40% | -80.0% |
| UMRX | Sell | UNUM THERAPEUTICS INC | $2,078,000 | -17.0% | 473,441 | -16.8% | 0.31% | -13.0% |
| WMGIZ | Exit | WRIGHT MED GROUP N Vright 03/01/2019 | $0 | – | -4,622,032 | -100.0% | -0.01% | – |
| C | Exit | CITIGROUP INC | $0 | – | -52,500 | -100.0% | -0.38% | – |
| MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -1,269,145 | -100.0% | -0.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.